295 related articles for article (PubMed ID: 32683996)
1. Co-amorphous systems for the delivery of poorly water-soluble drugs: recent advances and an update.
Han J; Wei Y; Lu Y; Wang R; Zhang J; Gao Y; Qian S
Expert Opin Drug Deliv; 2020 Oct; 17(10):1411-1435. PubMed ID: 32683996
[TBL] [Abstract][Full Text] [Related]
2. Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.
Shi Q; Wang Y; Moinuddin SM; Feng X; Ahsan F
AAPS PharmSciTech; 2022 Sep; 23(7):259. PubMed ID: 36123515
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in co-amorphous drug formulations.
Dengale SJ; Grohganz H; Rades T; Löbmann K
Adv Drug Deliv Rev; 2016 May; 100():116-25. PubMed ID: 26805787
[TBL] [Abstract][Full Text] [Related]
4. On the role of salt formation and structural similarity of co-formers in co-amorphous drug delivery systems.
Wu W; Löbmann K; Rades T; Grohganz H
Int J Pharm; 2018 Jan; 535(1-2):86-94. PubMed ID: 29102703
[TBL] [Abstract][Full Text] [Related]
5. Refining stability and dissolution rate of amorphous drug formulations.
Grohganz H; Priemel PA; Löbmann K; Nielsen LH; Laitinen R; Mullertz A; Van den Mooter G; Rades T
Expert Opin Drug Deliv; 2014 Jun; 11(6):977-89. PubMed ID: 24754747
[TBL] [Abstract][Full Text] [Related]
6. Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability.
Liu X; Shen L; Zhou L; Wu W; Liang G; Zhao Y; Wu W
Eur J Pharm Biopharm; 2024 Jul; 200():114333. PubMed ID: 38768766
[TBL] [Abstract][Full Text] [Related]
7. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
Cherniakov I; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.
Mahmood T; Sarfraz RM; Ismail A; Ali M; Khan AR
Assay Drug Dev Technol; 2023; 21(2):65-79. PubMed ID: 36917562
[No Abstract] [Full Text] [Related]
9. Emerging trends in the stabilization of amorphous drugs.
Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
[TBL] [Abstract][Full Text] [Related]
10. Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs.
Davis M; Walker G
J Control Release; 2018 Jan; 269():110-127. PubMed ID: 29117503
[TBL] [Abstract][Full Text] [Related]
11. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.
Shi Q; Li F; Yeh S; Moinuddin SM; Xin J; Xu J; Chen H; Ling B
AAPS PharmSciTech; 2021 Dec; 23(1):16. PubMed ID: 34893936
[TBL] [Abstract][Full Text] [Related]
13. Insights into co-amorphous systems in therapeutic drug delivery.
Singh R; Joshi V; Mehetre N; Sangamwar AT
Ther Deliv; 2021 Mar; 12(3):245-265. PubMed ID: 33745286
[TBL] [Abstract][Full Text] [Related]
14. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability Improvement Strategies for Poorly Water-Soluble Drugs Based on the Supersaturation Mechanism: An Update.
Yang M; Gong W; Wang Y; Shan L; Li Y; Gao C
J Pharm Pharm Sci; 2016; 19(2):208-25. PubMed ID: 27518171
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
[TBL] [Abstract][Full Text] [Related]
17. Nanonization techniques to overcome poor water-solubility with drugs.
Da Silva FLO; Marques MBF; Kato KC; Carneiro G
Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
[TBL] [Abstract][Full Text] [Related]
18. Promising strategies for improving oral bioavailability of poor water-soluble drugs.
Rocha B; de Morais LA; Viana MC; Carneiro G
Expert Opin Drug Discov; 2023 Jun; 18(6):615-627. PubMed ID: 37157841
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs.
Wang H; Zhao P; Ma R; Jia J; Fu Q
Drug Discov Today; 2024 Feb; 29(2):103883. PubMed ID: 38219970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
